|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dai C, Lv S, Shi R, Ding J, Zhong X, Song
H, Ma X, Fan J, Sun B, Wang R, et al: Nuclear protein C23 on the
cell surface plays an important role in activation of CXCR4
signaling in glioblastoma. Mol Neurobiol. 52:1521–1526. 2015.
View Article : Google Scholar
|
|
4
|
Janga SC and Vallabhaneni S: MicroRNAs as
post-transcriptional machines and their interplay with cellular
networks. Adv Exp Med Biol. 722:59–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ong CA, Lao-Sirieix P and Fitzgerald RC:
Biomarkers in Barrett's esophagus and esophageal adenocarcinoma:
Predictors of progression and prognosis. World J Gastroenterol.
16:5669–5681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du M, Shi D, Yuan L, Li P, Chu H, Qin C,
Yin C, Zhang Z and Wang M: Circulating miR-497 and miR-663b in
plasma are potential novel biomarkers for bladder cancer. Sci Rep.
5:104372015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Lei Q, Yu Z, Xu G, Tang H, Wang W,
Wang Z, Li G and Wu M: MiR-101 reverses the hypomethylation of the
LMO3 promoter in glioma cells. Oncotarget. 6:7930–7943. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G,
Xiang J, Wu M and Li G: miR-128 and miR-149 enhance the
chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal
remodeling in glioblastoma. Oncol Rep. 32:957–964. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang H, Liu X, Wang Z, She X, Zeng X, Deng
M, Liao Q, Guo X, Wang R, Li X, et al: Interaction of hsa-miR-381
and glioma suppressor LRRC4 is involved in glioma growth. Brain
Res. 1390:21–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song S, Fajol A, Tu X, Ren B and Shi S:
miR-204 suppresses the development and progression of human
glioblastoma by targeting ATF2. Oncotarget. 7:70058–70065.
2016.PubMed/NCBI
|
|
12
|
Song H, Zhang Y, Liu N, Wan C, Zhang D,
Zhao S, Kong Y and Yuan L: miR-92b regulates glioma cells
proliferation, migration, invasion, and apoptosis via PTEN/Akt
signaling pathway. J Physiol Biochem. 72:201–211. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li S, Zeng A, Hu Q, Yan W, Liu Y and You
Y: miR-423-5p contributes to a malignant phenotype and temozolomide
chemo-resistance in glioblastomas. Neurooncol. 19:55–65. 2017.
|
|
14
|
Song H and Bu G: MicroRNA-205 inhibits
tumor cell migration through down-regulating the expression of the
LDL receptor-related protein 1. Biochem Biophys Res Commun.
388:400–405. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du
F, Liu LJ, Liu YH, Liu XD, Jia JF, et al: Identification of
microRNA-205 as a potential prognostic indicator for human glioma.
J Clin Neurosci. 20:933–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boll K, Reiche K, Kasack K, Mörbt N,
Kretzschmar AK, Tomm JM, Verhaegh G, Schalken J, von Bergen M, Horn
F, et al: MiR-130a, miR-203 and miR-205 jointly repress key
oncogenic pathways and are downregulated in prostate carcinoma.
Oncogene. 32:277–285. 2013. View Article : Google Scholar
|
|
17
|
Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger
B, Guo J and Xu X: Loss of microRNA-205 expression is associated
with melanoma progression. Lab Invest. 92:1084–1096. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu H, Wang H, Liu X and Yu T: miR-1271
inhibits migration, invasion and epithelial-mesenchymal transition
by targeting ZEB1 and TWIST1 in pancreatic cancer cells. Biochem
Biophys Res Commun. 472:346–352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siebzehnrubl FA, Silver DJ, Tugertimur B,
Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT,
Kupper MD, Neal D, et al: The ZEB1 pathway links glioblastoma
initiation, invasion and chemoresistance. EMBO Mol Med.
5:1196–1212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aigner K, Dampier B, Descovich L, Mikula
M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist
P, et al: The transcription factor ZEB1 (deltaEF1) promotes tumour
cell dedifferentiation by repressing master regulators of
epithelial polarity. Oncogene. 26:6979–6988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun X, Li Y, Yu J, Pei H, Luo P and Zhang
J: miR-128 modulates chemosensitivity and invasion of prostate
cancer cells through targeting ZEB1. Jpn J Clin Oncol. 45:474–482.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Cao H, Xu D and Zhu K:
MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by
targeting the PTEN/ AKT pathway. Onco Targets Ther. 9:3579–3588.
2016.
|
|
25
|
Guo K, Zheng S, Xu Y, Xu A, Chen B and Wen
Y: Loss of miR-26a-5p promotes proliferation, migration, and
invasion in prostate cancer through negatively regulating SERBP1.
Tumour Biol. 37:12843–12854. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu S, Huang S, Ding J, Zhao Y, Liang L,
Liu T, Zhan R and He X: Multiple microRNAs modulate p21Cip1/Waf1
expression by directly targeting its 3′ untranslated region.
Oncogene. 29:2302–2308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
LeBlanc VC and Morin P Jr: Exploring
miRNA-associated signatures with diagnostic relevance in
glioblastoma multiforme and breast cancer patients. J Clin Med.
4:1612–1630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shea A, Harish V, Afzal Z, Chijioke J,
Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, et
al: MicroRNAs in glioblastoma multiforme pathogenesis and
therapeutics. Cancer Med. 5:1917–1946. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo JW, Wang X, Yang Y and Mao Q: Role of
micro-RNA (miRNA) in pathogenesis of glioblastoma. Eur Rev Med
Pharmacol Sci. 19:1630–1639. 2015.PubMed/NCBI
|
|
30
|
Wang H, Tao T, Yan W, Feng Y, Wang Y, Cai
J, You Y, Jiang T and Jiang C: Upregulation of miR-181s reverses
mesenchymal transition by targeting KPNA4 in glioblastoma. Sci Rep.
5:130722015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan Y, Wu J, Wu M, Xia Y, Tang W and Liao
Z: MiR-143 suppresses the epithelial-mesenchymal transition of
spinal glioblastoma through down-regulation of ERK5. Oncotarget:
oncotarget. pp. 12977
|
|
32
|
Puhr M, Hoefer J, Schäfer G, Erb HH, Oh
SJ, Klocker H, Heidegger I, Neuwirt H and Culig Z:
Epithelial-to-mesenchymal transition leads to docetaxel resistance
in prostate cancer and is mediated by reduced expression of
miR-200c and miR-205. Am J Pathol. 181:2188–2201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Shan M, Liu Y, Yang F, Qi H, Zhou
L, Qiu L and Li Y: miR-205 suppresses the proliferative and
migratory capacity of human osteosarcoma Mg-63 cells by targeting
VEGFA. Onco Targets Ther. 8:2635–2642. 2015.PubMed/NCBI
|
|
34
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsushima K, Isomoto H, Yamaguchi N,
Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S,
Nagayasu T, et al: MiRNA-205 modulates cellular invasion and
migration via regulating zinc finger E-box binding homeobox 2
expression in esophageal squamous cell carcinoma cells. J Transl
Med. 9:302011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu C, Li M, Zhang L, Bi Y, Wang P, Li J
and Jiang X: MicroRNA-205 suppresses the invasion and
epithelial-mesen-chymal transition of human gastric cancer cells.
Mol Med Rep. 13:4767–4773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou G, Zhang F, Guo Y, Huang J, Xie Y,
Yue S, Chen M, Jiang H and Li M: miR-200c enhances sensitivity of
drug-resistant non-small cell lung cancer to gefitinib by
suppression of PI3K/Akt signaling pathway and inhibites cell
migration via targeting ZEB1. Biomed Pharmacother. 85:113–119.
2017. View Article : Google Scholar
|
|
39
|
Mao Y, Wu S, Zhao R and Deng Q: MiR-205
promotes proliferation, migration and invasion of nasopharyngeal
carcinoma cells by activation of AKT signalling. J Int Med Res.
44:231–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Williams TM, Moolten D, Burlein J, Romano
J, Bhaerman R, Godillot A, Mellon M, Rauscher FJ III and Kant JA:
Identification of a zinc finger protein that inhibits IL-2 gene
expression. Science. 254:1791–1794. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang
P, He X, Wang Q, Huang Y, Jen KY, et al: CUL4A induces
epithelial-mesenchymal transition and promotes cancer metastasis by
regulating ZEB1 expression. Cancer Res. 74:520–531. 2014.
View Article : Google Scholar :
|
|
42
|
Ohashi S, Natsuizaka M, Naganuma S, Kagawa
S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, et
al: A NOTCH3-mediated squamous cell differentiation program limits
expansion of EMT-competent cells that express the ZEB transcription
factors. Cancer Res. 71:6836–6847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Eger A, Aigner K, Sonderegger S, Dampier
B, Oehler S, Schreiber M, Berx G, Cano A, Beug H and Foisner R:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qu J, Li M, An J, Zhao B, Zhong W, Gu Q,
Cao L, Yang H and Hu C: MicroRNA-33b inhibits lung adenocarcinoma
cell growth, invasion, and epithelial-mesenchymal transition by
suppressing Wnt/β-catenin/ZEB1 signaling. Int J Oncol.
47:2141–2152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun K, Zeng T, Huang D, Liu Z, Huang S,
Liu J and Qu Z: MicroRNA-431 inhibits migration and invasion of
hepatocellular carcinoma cells by targeting the ZEB1-mediated
epithelial-mensenchymal transition. FEBS Open Bio. 5:900–907. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pang H, Zheng Y, Zhao Y, Xiu X and Wang J:
miR-590-3p suppresses cancer cell migration, invasion and
epithelial-mesenchymal transition in glioblastoma multiforme by
targeting ZEB1 and ZEB2. Biochem Biophys Res Commun. 468:739–745.
2015. View Article : Google Scholar : PubMed/NCBI
|
